OBINUTUZUMAB
obinutuzumab 1 g/40 mL injection, 40 mL vial
OBINUTUZUMAB (15526E)
15526E
Manner of administration:Injection
Restriction
Indication: Lupus nephritis
Treatment phase: Subsequent continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 0 | DPMQ: $4,299.24 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Gazyva | |||||